Cytokine response to diabetic ketoacidosis and its treatment

William H. Hoffman, C. Lynne Burek, Jennifer L Waller, Lyle E Fisher, Mahmood Khichi, Larry B Mellick

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The objectives of this study were to monitor plasma cytokines as markers of cellular activation and as potential markers for the progression of the acute complications of diabetic ketoacidosis (DKA). Blood samples were obtained prior to, during and after treatment of severe DKA (pH < 7.2) in six children and adolescents. Plasma IL-10, IL-1β, TNF-α, IL-6, IL-8 and IL-2 cytokine levels were assayed by ELISA at each of the time points. Prior to treatment, elevations of multiple cytokines were found, the highest being IL-10. Treatment of DKA resulted in a significant decrease of IL-10 at 6-8 h (p = 0.0062), and further increases in the inflammatory cytokines at 6-8 h and/or 24 h vs 120 h (baseline): IL-1β (p = .0048); TNF-α (p = .0188) and IL-8 (p = .0048). This study strengthens the hypothesis that the metabolic crisis of DKA, and its treatment, have differential effects on cellular activation and cytokine release. The time frame for the increase in inflammatory cytokines correlates with the reported progression of subclinical brain edema, interstitial pulmonary edema and the development of clinical brain edema.

Original languageEnglish (US)
Pages (from-to)175-181
Number of pages7
JournalClinical Immunology
Volume108
Issue number3
DOIs
StatePublished - Sep 1 2003

Fingerprint

Diabetic Ketoacidosis
Cytokines
Interleukin-10
Brain Edema
Interleukin-8
Interleukin-1
Therapeutics
Pulmonary Edema
Interleukin-2
Interleukin-6
Enzyme-Linked Immunosorbent Assay

Keywords

  • Cellular activation
  • Cytokines
  • Diabetic ketoacidosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cytokine response to diabetic ketoacidosis and its treatment. / Hoffman, William H.; Burek, C. Lynne; Waller, Jennifer L; Fisher, Lyle E; Khichi, Mahmood; Mellick, Larry B.

In: Clinical Immunology, Vol. 108, No. 3, 01.09.2003, p. 175-181.

Research output: Contribution to journalArticle

Hoffman, William H. ; Burek, C. Lynne ; Waller, Jennifer L ; Fisher, Lyle E ; Khichi, Mahmood ; Mellick, Larry B. / Cytokine response to diabetic ketoacidosis and its treatment. In: Clinical Immunology. 2003 ; Vol. 108, No. 3. pp. 175-181.
@article{5394517c5be94ff48e280f0e509002a4,
title = "Cytokine response to diabetic ketoacidosis and its treatment",
abstract = "The objectives of this study were to monitor plasma cytokines as markers of cellular activation and as potential markers for the progression of the acute complications of diabetic ketoacidosis (DKA). Blood samples were obtained prior to, during and after treatment of severe DKA (pH < 7.2) in six children and adolescents. Plasma IL-10, IL-1β, TNF-α, IL-6, IL-8 and IL-2 cytokine levels were assayed by ELISA at each of the time points. Prior to treatment, elevations of multiple cytokines were found, the highest being IL-10. Treatment of DKA resulted in a significant decrease of IL-10 at 6-8 h (p = 0.0062), and further increases in the inflammatory cytokines at 6-8 h and/or 24 h vs 120 h (baseline): IL-1β (p = .0048); TNF-α (p = .0188) and IL-8 (p = .0048). This study strengthens the hypothesis that the metabolic crisis of DKA, and its treatment, have differential effects on cellular activation and cytokine release. The time frame for the increase in inflammatory cytokines correlates with the reported progression of subclinical brain edema, interstitial pulmonary edema and the development of clinical brain edema.",
keywords = "Cellular activation, Cytokines, Diabetic ketoacidosis",
author = "Hoffman, {William H.} and Burek, {C. Lynne} and Waller, {Jennifer L} and Fisher, {Lyle E} and Mahmood Khichi and Mellick, {Larry B}",
year = "2003",
month = "9",
day = "1",
doi = "10.1016/S1521-6616(03)00144-X",
language = "English (US)",
volume = "108",
pages = "175--181",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Cytokine response to diabetic ketoacidosis and its treatment

AU - Hoffman, William H.

AU - Burek, C. Lynne

AU - Waller, Jennifer L

AU - Fisher, Lyle E

AU - Khichi, Mahmood

AU - Mellick, Larry B

PY - 2003/9/1

Y1 - 2003/9/1

N2 - The objectives of this study were to monitor plasma cytokines as markers of cellular activation and as potential markers for the progression of the acute complications of diabetic ketoacidosis (DKA). Blood samples were obtained prior to, during and after treatment of severe DKA (pH < 7.2) in six children and adolescents. Plasma IL-10, IL-1β, TNF-α, IL-6, IL-8 and IL-2 cytokine levels were assayed by ELISA at each of the time points. Prior to treatment, elevations of multiple cytokines were found, the highest being IL-10. Treatment of DKA resulted in a significant decrease of IL-10 at 6-8 h (p = 0.0062), and further increases in the inflammatory cytokines at 6-8 h and/or 24 h vs 120 h (baseline): IL-1β (p = .0048); TNF-α (p = .0188) and IL-8 (p = .0048). This study strengthens the hypothesis that the metabolic crisis of DKA, and its treatment, have differential effects on cellular activation and cytokine release. The time frame for the increase in inflammatory cytokines correlates with the reported progression of subclinical brain edema, interstitial pulmonary edema and the development of clinical brain edema.

AB - The objectives of this study were to monitor plasma cytokines as markers of cellular activation and as potential markers for the progression of the acute complications of diabetic ketoacidosis (DKA). Blood samples were obtained prior to, during and after treatment of severe DKA (pH < 7.2) in six children and adolescents. Plasma IL-10, IL-1β, TNF-α, IL-6, IL-8 and IL-2 cytokine levels were assayed by ELISA at each of the time points. Prior to treatment, elevations of multiple cytokines were found, the highest being IL-10. Treatment of DKA resulted in a significant decrease of IL-10 at 6-8 h (p = 0.0062), and further increases in the inflammatory cytokines at 6-8 h and/or 24 h vs 120 h (baseline): IL-1β (p = .0048); TNF-α (p = .0188) and IL-8 (p = .0048). This study strengthens the hypothesis that the metabolic crisis of DKA, and its treatment, have differential effects on cellular activation and cytokine release. The time frame for the increase in inflammatory cytokines correlates with the reported progression of subclinical brain edema, interstitial pulmonary edema and the development of clinical brain edema.

KW - Cellular activation

KW - Cytokines

KW - Diabetic ketoacidosis

UR - http://www.scopus.com/inward/record.url?scp=0141788730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141788730&partnerID=8YFLogxK

U2 - 10.1016/S1521-6616(03)00144-X

DO - 10.1016/S1521-6616(03)00144-X

M3 - Article

C2 - 14499240

AN - SCOPUS:0141788730

VL - 108

SP - 175

EP - 181

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -